GLP-1 and Endometriosis: What Women Need to Know About This Connection

If you're living with endometriosis, you know how deeply it can affect every aspect of your life. The chronic pain, the unpredictable flare-ups, the toll it takes on your metabolic health—it's exhausting. Now, researchers are discovering something unexpected: GLP-1 medications, originally developed for type 2 diabetes and weight management, may offer benefits for women dealing with endometriosis. While this connection is still being studied, what we're learning is genuinely promising.

Understanding Endometriosis and Its Metabolic Impact

Endometriosis affects roughly 10% of women of reproductive age—that's approximately 190 million women worldwide. It occurs when tissue similar to the uterine lining grows outside the uterus, causing inflammation, pain, and often, fertility challenges.

What many women don't realize is that endometriosis doesn't just cause pelvic pain. It's increasingly recognized as a systemic inflammatory condition that can affect your entire metabolic system.

Women with endometriosis often experience:

• Insulin resistance and difficulty managing blood sugar
• Higher rates of weight gain, particularly around the abdomen
• Increased inflammation throughout the body
• Greater risk of developing metabolic syndrome
• Challenges with weight management despite healthy habits

This metabolic connection is where GLP-1 medications enter the picture.

What Are GLP-1 Medications?

GLP-1 (glucagon-like peptide-1) receptor agonists are a class of medications that mimic a hormone your body naturally produces. This hormone helps regulate blood sugar, reduces appetite, and slows digestion.

Common GLP-1 medications include semaglutide (brand names Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound). While initially developed for type 2 diabetes, these medications have shown remarkable benefits for weight management and are now being studied for their anti-inflammatory properties.

How GLP-1 Works in Your Body

When you take a GLP-1 medication, it works through several mechanisms:

• Stimulates insulin production when blood sugar is elevated
• Reduces glucagon, which lowers glucose production in the liver
• Slows stomach emptying, helping you feel full longer
• Acts on brain receptors that regulate appetite
• May reduce systemic inflammation

It's this last point—reducing inflammation—that's particularly interesting for endometriosis management.

The Connection Between GLP-1 and Endometriosis

Research into GLP-1 and endometriosis is still emerging, but early findings are compelling. Studies suggest that GLP-1 receptor agonists may help address several aspects of endometriosis through multiple pathways.

Reducing Inflammation

Endometriosis is fundamentally an inflammatory disease. The misplaced tissue triggers immune responses that create chronic inflammation throughout the pelvic region and beyond.

GLP-1 medications have demonstrated anti-inflammatory effects in multiple studies. They may help reduce the inflammatory cytokines that contribute to endometriosis pain and progression. While we need more research specific to endometriosis, the anti-inflammatory properties of GLP-1s are well-documented in other chronic inflammatory conditions.

Improving Insulin Sensitivity

Many women with endometriosis develop insulin resistance, even without having diabetes. This can create a vicious cycle: insulin resistance promotes inflammation, which may worsen endometriosis symptoms, which further impacts metabolic health.

GLP-1 medications directly improve insulin sensitivity, potentially breaking this cycle. Better blood sugar control may translate to reduced inflammation and improved overall symptom management.

Supporting Weight Management

Weight management is often particularly challenging for women with endometriosis. The condition itself, combined with hormonal treatments commonly prescribed for it, can make maintaining a healthy weight difficult.

Excess weight, especially abdominal fat, produces inflammatory compounds that may worsen endometriosis. GLP-1 medications can support meaningful weight loss, which may in turn help reduce the inflammatory burden.

What the Research Shows

While large-scale studies specifically examining GLP-1 medications for endometriosis are still needed, related research is encouraging.

Studies on GLP-1 receptor agonists have shown:

• Significant reductions in inflammatory markers like C-reactive protein
• Improvements in conditions often linked with endometriosis, such as PCOS
• Benefits for metabolic dysfunction associated with chronic inflammatory conditions
• Potential protective effects on reproductive health

Some researchers theorize that by addressing the metabolic and inflammatory aspects of endometriosis, GLP-1 medications might offer complementary benefits alongside traditional endometriosis treatments.

Important Considerations for Women with Endometriosis

If you're considering a GLP-1 medication for endometriosis-related concerns, there are several important points to discuss with your healthcare provider.

GLP-1 Is Not a Replacement for Endometriosis Treatment

These medications should not be viewed as a cure or primary treatment for endometriosis. Standard treatments—whether hormonal therapies, pain management, or surgery—remain essential. GLP-1 medications may offer complementary benefits, particularly for metabolic health and inflammation.

Individual Response Varies

Every woman's experience with both endometriosis and GLP-1 medications is unique. What works beautifully for one person may not provide the same benefits for another. Close monitoring with your healthcare team is essential.

Fertility Considerations

If you're trying to conceive, it's crucial to discuss this with your doctor. GLP-1 medications are not recommended during pregnancy, and you should stop them before attempting conception. That said, for women not currently trying to get pregnant, addressing metabolic health and inflammation may support overall reproductive health.

A Note About Men and GLP-1

While endometriosis specifically affects people with uteruses, men can also benefit from understanding GLP-1 medications—whether supporting a partner with endometriosis or considering these medications for their own metabolic health needs. GLP-1 receptor agonists are prescribed for both men and women for weight management and blood sugar control, with similar efficacy across genders.

From the Ozari Care Team

If you're managing endometriosis alongside weight concerns or metabolic issues, it's worth having a conversation about whether a GLP-1 medication might fit into your overall care plan. We often see women with chronic inflammatory conditions experience meaningful improvements in energy, inflammation markers, and quality of life when metabolic health is optimized. Your endometriosis treatment remains the foundation, but addressing metabolic factors can be a valuable complement.

Moving Forward with Informed Choices

The connection between GLP-1 medications and endometriosis represents an exciting frontier in women's health. While we're still learning, the potential for these medications to address the metabolic and inflammatory aspects of endometriosis offers new hope for comprehensive management.

If you're struggling with endometriosis and its metabolic effects, you don't have to navigate this alone. A knowledgeable healthcare provider can help you determine whether a GLP-1 medication might be appropriate as part of your overall treatment strategy.

At Ozari Health, we offer compounded Semaglutide and Tirzepatide starting at $99/month, prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically reviewed by the Ozari Clinical Care Team, licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 26, 2026